Abstract: A method is disclosed herein. The method includes the step of capturing and concentrating CO2 from atmospheric air by utilizing geothermal heat to provide the energy needed to move the atmospheric air through a tower.

Abstract: A system for removing CO2 from air such as atmospheric air is described that uses a cooling tower, a pseudo-cooling tower, or a wind capture device to provide a large volume of atmospheric air. A CO2 capture apparatus is positioned to contact atmospheric air moving towards or within the cooling tower, pseudo-tower, or wind capture device, and includes wherein the CO2 capture apparatus includes a CO2 binding agent that binds to CO2 in atmospheric air. An associated reprocessing apparatus releases C02 from the binding agent, directs the released CO2 to a CO2 storage chamber, and returns the binding agent to the CO2 capture apparatus. A system for removing CO2 from flue gas is also described.

Abstract: A method of treating a mammal for the presence or the activity of H. pylori in the gastrointestinal tract is disclosed. The method encompasses orally administering to said mammal a sufficient amount of a scavenging, reacting or inactivating compound to remove bicarbonate ions, ammonium ions or urea which are present in combination with the microorganisms which colonize and infect the gastric mucosa. Such microorganisms have been implicated in gastritis, gastric ulcer disease and as a risk factor in gastric carcinoma.Also, the invention encompasses a method, utilizing similar compounds, for the treatment or prevention of dermatitis such as diaper rash wherein these compounds are preapplied to the skin or used to treat the diaper prior to use.Also included are compositions which are used for the methods described above.

Abstract: A disposable container/dispenser assembly for the extended storage and direct intravenous administration of a medicament includes a syringe barrel defining a main chamber for containing a liquid, the barrel including an upper opening in communication with the main chamber; an auxiliary barrel defining an auxiliary chamber for containing a drug to be mixed with the liquid, the auxiliary barrel including second and third spaced and opposing openings in communication with the auxiliary chamber; a first impermeable membrane for sealing the first opening of the main body; a second impermeable membrane for sealing the second opening of the auxiliary body; the first and second openings being in line with each other when the auxiliary body is connected with the main body; a third impermeable membrane secured to the auxiliary body for covering and sealing the third opening; and a plunger slidably positioned outside of the auxiliary body for rupturing the first through third membranes.

Abstract: A medicament container/dispenser assembly includes a substantially non-collapsible main body defining a chamber for containing the medicament in liquid form, the main body having an upper portion and a lower portion; an opening formed in the upper portion; a liquid impervious, gas permeable membrane secured to the upper portion of the main body in sealing relation to the opening; a rupturable exit port formed in the lower portion of the main body. The assembly may also include a second opening formed in the upper portion of the main body in spaced relation to the first-mentioned opening and an elastomeric, puncturable, sealing material secured to the upper portion of the main body in sealing relation to the second opening. In a further embodiment, a conduit may be positioned adjacent the membrane at the upper section of the main body, and may contain a blower for supplying forced air to the membrane through the conduit.

Abstract: A new and useful particulate magnesium phosphate product (MGP) and method of use therefor are disclosed for removing ammonia from aqueous solutions, e.g., recirculating dialysate solutions and intragastrointestinal fluids as may result from the hydrolysis of urea. This particulate magnesium phosphate product (MGP) acts as a remarkably effective scavenger wherein under equilibrium conditions only about six (6) grams of the novel product are required to bind the ammonia (more exactly, ammonium ions) liberated from one (1) gram of the urea, a result far superior to traditional zirconium phosphate (ZP) prior art materials which under ideal conditions require about 17-20 grams of ZP per gram of urea. The novel particulate magnesium phosphate product can be exploited in one embodiment as a replacement for the older ZP materials used to remove ammonia produced by enzymatic hydrolysis of urea in recirculating dialysis systems utilizing disposable cartridges.

Abstract: A new and useful all plastic disposable thermometer is disclosed, which dispenses with the prior art employment of an aluminum or other metal-based substrate. The novel thermometer can either be employed with opaque indicator means or with heat-sensitive compositions of matter that change color with a change in phase, such as those enumerated in copending application Ser. No. 946,935, filed Sept. 28, 1978, now U.S. Pat. No. 4,232,552.